It's a 2010 paper, but it's one of the better overviews of the industry I've run across. Shows Valence in top 10 of global patent holders - neither A123 or JCI included on that list - most of the list is non-US companies - US outfits are behind the curve on Li-On in many respects according to the paper - JCI is up there in manufacturing capability, but not IP. A123 had a plant here, and one problem I've had is trying to separate what they were willing to bid on A123 between IP and PP&E - from this and your posts earlier Paolo - JCI doesn't appear to need capacity currently - which leads me to guess the bid was based much more heavily toward the IP; high cost plant may very well have been a liability.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.